Exemestane Tablet
Product Images NDC 68382-383

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 68382-383). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 01

3141272d 8016 4ad6 Ba31 A8a62fde27ce 01
Chemical structure diagram of Exemestane, showing its steroidal core with multiple carbon rings and functional groups including methyl groups and ketone groups.*
FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 02

3141272d 8016 4ad6 Ba31 A8a62fde27ce 02
A survival curve chart comparing the duration of disease-free survival (in months) for patients treated with Exemestane versus Tamoxifen. The chart displays proportion surviving on the vertical axis, with Exemestane represented by a red solid line and Tamoxifen by a blue dashed line. The chart includes hazard ratio (HR) and p-value statistics along with the number of events and patients for each treatment group.*
FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 03

3141272d 8016 4ad6 Ba31 A8a62fde27ce 03
A Kaplan-Meier survival probability curve comparing Exemestane and Megestrol Acetate over time in weeks. The graph shows probability on the y-axis and weeks on the x-axis, with Exemestane represented by a solid magenta line and Megestrol Acetate by a black dashed line, indicating patient outcomes over approximately 140 weeks.*
FDA Label Image

3141272d 8016 4ad6 Ba31 A8a62fde27ce 04

3141272d 8016 4ad6 Ba31 A8a62fde27ce 04
Label for Exemestane Tablets, USP 25 mg oral tablets. The label indicates a package containing 30 tablets with prescription only status. The label includes dosage information, storage instructions, manufacturer Cadila Healthcare Ltd. from India, and distributor Zydus Pharmaceuticals USA Inc. It also notes the package is child-resistant and lists the NDC as 68382-383-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.